Hope in prostate cancer: biomarkers in semen

A study by the Pere Virgili Health Research Institute (IISPV) and the Urology Service of the Joan XXIII University Hospital in Tarragona has explored a panel of biomarkers detectable in semen samples with “promising results” when combined with traditional clinical variables.

The preliminary data, published in an article in Journal of Urologysuggest that this approach could help in early detection, the identification of patients with a higher risk of recurrence after treatment with curative intent and the follow-up of patients under active surveillance for this tumor, the IISPV reports in a statement this Tuesday.

The advance represents “a relevant step” towards personalized medicine in urology and, although more prospective studies with a larger number of patients are required, the results obtained so far are highly promising, according to the researchers.